Status:
COMPLETED
Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Current Every Day Smoker
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This randomized clinical trial studies how well a smartphone-delivered attentional bias modification training works in helping patients quit smoking. Smartphone-delivered attentional bias modification...
Detailed Description
PRIMARY OBJECTIVES: I. To determine the feasibility of smartphone-delivered, in-home attentional bias modification (ABM) to reduce attentional bias (AB) to smoking cues and to reduce smoking behavior...
Eligibility Criteria
Inclusion
- Smoke an average of 5 or more cigarettes or little cigars per day (CPD) prior to telephone screen
- Produce an expired carbon monoxide (CO) level greater than or equal to 6 parts per million (ppm) or a NicAlert reading of \> 2
- Have a working telephone
- Interested in quitting smoking in the next 30 days
- Fluency in spoken and written English
- Must sign the picture consent form
Exclusion
- Taking psychotropic, anticonvulsive, or narcotic medication
- Meet criteria for a current major depressive episode or suicidality
- Have a history of neurological illness or closed head injury
- Report uncorrected vision problems
- Involved in current smoking cessation activity
- Testing positive on a urine drug screen for drugs of abuse/potential abuse
- Women who are pregnant or breastfeeding
- Considered by the investigator to be an unsuitable or unstable candidate (e.g., due to cognitive impairment)
- Shares the same address as a currently enrolled participant
- Unwilling to alter or remove hairstyle, hair extensions, or wig during the clinic visits to allow for correct electroencephalography (EEG) sensor placement
- Reports diagnosis of seizure disorder
- Unwilling to use nicotine replacement therapy (NRT) patches
Key Trial Info
Start Date :
January 20 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2021
Estimated Enrollment :
311 Patients enrolled
Trial Details
Trial ID
NCT02224391
Start Date
January 20 2016
End Date
March 15 2021
Last Update
March 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030